Company Name: eBroselow LLC
About: SafeDose® is an electronic medication reference tool. It contains acute
medications provided for pre-hospital and hospital workers by SafeDose as a
public service.
The following contact options are available: Pricing Information, Support, General Help, and Press Information/New Coverage (to guage reputation). Discover which options are the fastest to get your customer service issues resolved.
NOTE: If the links below doesn't work for you, Please go directly to the Homepage of eBroselow LLC
E-Mail: [email protected]
Website: 🌍 Visit SafeDosePro Website
Privacy Policy: https://www.safedoseinc.com/sdi-information-security-policy/
Developer: SafeDose
Protect your data and wallet. We investigate the developer's website (Ebroselow.com), verify they're legit, and uncover hidden scams or complaints.
by DragonEyes76
I paid a full version for $20 when apps were at $0.99. I never asked for updates. I was ok using the prior version and all of a sudden they changed it to exorbitant subscription prices
by Pediatricdoc
Most of my work is in the outpatient clinic and the newborn nursery, but I do occasionally get called to pediatric emergencies.
I bought this app years ago and was very happy to have it on my phone and accessible. I did, in fact, use it several times in the emergency room.
I received no notice whatsoever that my access to this app would no longer be valid. I’m fortunate to have discovered this in a non-emergency setting, but seriously – this was an extraordinarily dangerous thing to do.
by Mccall MD
Safe Dose Pro was a great app at a great price. I recommended to all of my colleagues. I have used the app for over two years while working as an emergency medicine physician. I tried to open the app today and I cannot access the information. Safe Dose has decided to go to a subscription based model (after selling me the app). This is poor form to block content after selling an app to a customer. Tried to call customer service and got a recording. Too bad. Deleting the app now. Would no longer recommend, especially for $100/year. Getting greedy.